Recent studies indicated that chemotherapy drug–activated caspase-3 can also induce secondary necrosis/pyroptosis in both cancer and normal cells with expression of gasdermin E (GSDME), a member of the gasdermin family (Rogers et al., 2017; Wang et al., 2017). The gene discussed is CASP3; the disease is cancer.